Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001096906-22-000301

← back to feed
Filed
Feb 11, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Feb 11, 2022 209.9M sh
Short Term Debt Q2 2022 · Dec 31, 2021 $767.05K
Short Term Debt Q2 2022 · Jun 30, 2021 $752.51K
Stockholders Equity Q2 2022 · Dec 31, 2021 −$249.59K
Stockholders Equity Q2 2022 · Jun 30, 2021 −$223.53K
Current Liabilities Q2 2022 · Dec 31, 2021 $983.9K
Current Liabilities Q2 2022 · Jun 30, 2021 $954.71K
Total Liabilities Q2 2022 · Dec 31, 2021 $1.04M
Total Liabilities Q2 2022 · Jun 30, 2021 $1.01M
Current Assets Q2 2022 · Dec 31, 2021 $55.78K
Current Assets Q2 2022 · Jun 30, 2021 $66.67K
Total Assets Q2 2022 · Dec 31, 2021 $134.7K
Total Assets Q2 2022 · Jun 30, 2021 $134.12K
Operating Cash Flow Q2 2022 · Dec 31, 2020 −$71.83K
Cash And Equivalents Q2 2022 · Dec 31, 2020 $8.84K
Cash And Equivalents Q2 2022 · Jun 30, 2020 $15.28K
Sga Expense Q2 2022 · Dec 31, 2020 $11.87K
Sga Expense Q2 2022 · Dec 31, 2020 $23.62K
Rd Expense Q2 2022 · Dec 31, 2020 $2K
Rd Expense Q2 2022 · Dec 31, 2020 $4.42K
Net Income Q2 2022 · Dec 31, 2020 −$73.89K
Net Income Q2 2022 · Dec 31, 2020 −$148.78K
Operating Income Q2 2022 · Dec 31, 2020 −$38.3K
Operating Income Q2 2022 · Dec 31, 2020 −$82.71K
Gross Profit Q2 2022 · Dec 31, 2020 $10.69K
Gross Profit Q2 2022 · Dec 31, 2020 $30.57K
Revenue Q2 2022 · Dec 31, 2020 $10.69K
Revenue Q2 2022 · Dec 31, 2020 $30.57K